World News

The project aims to strengthen medical education while helping Sri Lanka train more healthcare professionals to meet growing national demand.

The rollout follows the device’s receipt of both CE mark and UK Conformity Assessed (UKCA) certification, allowing hospitals and healthcare providers in eligible European countries to begin purchasing the system.

The agreement was announced during the BIO International Convention 2026 in San Diego, California, and is expected to strengthen corneal transplantation services while improving access to sight-restoring care across the UAE and the wider region.

Under the collaboration, Insilico Medicine will use its proprietary Pharma.AI platform to identify and optimise drug candidates that meet predefined scientific and early development criteria.

The test detects the virus by identifying its genetic material in blood samples, allowing health workers to confirm infections quickly and accurately.

Verzenios is a cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitor developed by Lilly for the treatment of several forms of breast cancer.

The newly formed organization brings together four established healthcare brands including Aster DM, CARE Hospitals, Evercare and KIMSHEALTH, under a single platform focused on expanding access to advanced and affordable medical care across the country.

The Jasper, Indiana-based electronics and medical contract manufacturer will add Helvoet’s facilities in Tilburg, the Netherlands, and in Pune, India, to its global manufacturing network.

Under the agreement, QuantumCell will obtain global rights to AlzeCure’s NeuroRestore platform, including its lead drug candidate, ACD856.

Researchers can use the platform to design CRISPR screening experiments, analyse single-cell RNA sequencing data and generate three-dimensional protein structures, chemistry drawings and genome browser tracks.